Cas:23981-22-8 5-chloro-2-quinolone manufacturer & supplier

We serve Chemical Name:5-chloro-2-quinolone CAS:23981-22-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-chloro-2-quinolone

Chemical Name:5-chloro-2-quinolone
CAS.NO:23981-22-8
Synonyms:5-Chlor-2(1H)-chinolon;5-Chloro-2(1H)-quinolinone;5-chlorocarbostyril;2(1H)-Quinolinone, 5-chloro-;5-chloro-2-quinolinone;5-chloroquinolin-2(1H)-one
Molecular Formula:C9H6ClNO
Molecular Weight:179.603
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:372.6±42.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.609
PSA:32.86000
Exact Mass:179.013794
LogP:1.95

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Chlor-2(1H)-chinolon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloroquinolin-2(1H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloroquinolin-2(1H)-one Use and application,5-chlorocarbostyril technical grade,usp/ep/jp grade.


Related News: Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. 5-chloro-2-quinolone manufacturer Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. 5-chloro-2-quinolone supplier ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 5-chloro-2-quinolone vendor Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. 5-chloro-2-quinolone factory ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib.